贝里贝里二次导致牙.

The Emerging Short Chain Fatty Acid Enriched Metabotype in Irritable Bowel Syndrome and Its Potential Clinical Relevance.

Alimentary pharmacology & therapeutics·2026

Mortality in ulcerative colitis-what should we tell our patients? Three year mortality following admission for the treatment of ulcerative colitis: a 6 year retrospective case review.

Frontline gastroenterology·2017

Unique microbial-derived volatile organic compounds in portal venous circulation in murine non-alcoholic fatty liver disease.

Biochimica et biophysica acta·2016

Investigation of faecal volatile organic metabolites as novel diagnostic biomarkers in inflammatory bowel disease.

Alimentary pharmacology & therapeutics·2016

Review article: cytomegalovirus and inflammatory bowel disease.

Alimentary pharmacology & therapeutics·2015

The use of a gas chromatograph coupled to a metal oxide sensor for rapid assessment of stool samples from irritable bowel syndrome and inflammatory bowel disease patients.

Journal of breath research·2014

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Obstructive sleep apnea and periodontitis: a systematic review with considerations on CPAP therapy.

Acta odontologica Scandinavica·2026

Association of periodontal condition with insulin sensitivity - results of the Oulu1935 cohort study.

Acta odontologica Scandinavica·2026

Dental Calculus as a Potential Early Sign of Oral Functional Decline: A Hypothesis-Generating Case Series.

Cureus·2026

Radiographic and cone-beam computed tomography characterization of Chevron lucency in 82 clinically healthy maxillary canine teeth of dogs: a retrospective descriptive study.

Frontiers in veterinary science·2026

Computational formulation of a broad-spectrum multi-epitope vaccine against bacterial pathogens implicated in periodontal and systemic diseases.

3 Biotech·2026

Association of gingival crevicular fluid chemerin and Th1/Th2 imbalance with early response to root surface debridement in periodontitis.

Cytotechnology·2026

相关实验视频

贝里贝里二次导致牙

相关概念视频

The Emerging Short Chain Fatty Acid Enriched Metabotype in Irritable Bowel Syndrome and Its Potential Clinical Relevance.

Mortality in ulcerative colitis-what should we tell our patients? Three year mortality following admission for the treatment of ulcerative colitis: a 6 year retrospective case review.

Unique microbial-derived volatile organic compounds in portal venous circulation in murine non-alcoholic fatty liver disease.

Investigation of faecal volatile organic metabolites as novel diagnostic biomarkers in inflammatory bowel disease.

Review article: cytomegalovirus and inflammatory bowel disease.

The use of a gas chromatograph coupled to a metal oxide sensor for rapid assessment of stool samples from irritable bowel syndrome and inflammatory bowel disease patients.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Obstructive sleep apnea and periodontitis: a systematic review with considerations on CPAP therapy.

Association of periodontal condition with insulin sensitivity - results of the Oulu1935 cohort study.

Dental Calculus as a Potential Early Sign of Oral Functional Decline: A Hypothesis-Generating Case Series.

Radiographic and cone-beam computed tomography characterization of Chevron lucency in 82 clinically healthy maxillary canine teeth of dogs: a retrospective descriptive study.

Computational formulation of a broad-spectrum multi-epitope vaccine against bacterial pathogens implicated in periodontal and systemic diseases.

Association of gingival crevicular fluid chemerin and Th1/Th2 imbalance with early response to root surface debridement in periodontitis.

相关实验视频

贝里贝里二次导致牙

相关概念视频

相关文章